# Investors Title Co: overview

ITIC · Nasdaq · CIK 720858 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/itic.md) · [Financials](/companies/itic/financials.md) · [Filings](/companies/itic/filings.md) · [Insiders](/companies/itic/insiders.md)

Latest reported revenue: [$11.1m](/filings/0000720858-26-000030.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000720858-26-000030).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.9](/filings/0000720858-25-000032.md) | [9.1 d](/filings/0000720858-26-000011.md) | [8.5](/filings/0000720858-26-000017.md) | [11.2](/filings/0000720858-26-000030.md) | [11.1](/filings/0000720858-25-000032.md) | [10.2 d](/filings/0000720858-26-000011.md) | [9.4](/filings/0000720858-26-000017.md) | [11.1](/filings/0000720858-26-000030.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [104.9%](/filings/0000720858-25-000032.md) | [91.5% d](/filings/0000720858-26-000011.md) | [37.3%](/filings/0000720858-26-000017.md) | [109.9%](/filings/0000720858-26-000030.md) | [110.3%](/filings/0000720858-25-000032.md) | [73.9% d](/filings/0000720858-26-000011.md) | [64.5%](/filings/0000720858-26-000017.md) | [132.2%](/filings/0000720858-26-000030.md) |
| Diluted EPS | $ per share | [4.92](/filings/0000720858-25-000032.md) | not reported | [1.67](/filings/0000720858-26-000017.md) | [6.48](/filings/0000720858-26-000030.md) | [6.45](/filings/0000720858-25-000032.md) | not reported | [3.20](/filings/0000720858-26-000017.md) | [7.73](/filings/0000720858-26-000030.md) |
| Free cash flow | $m | [6.1 d](/filings/0000720858-25-000032.md) | [10.8 d](/filings/0000720858-26-000011.md) | [(1.4)](/filings/0000720858-26-000017.md) | [7.3 d](/filings/0000720858-26-000030.md) | [15.8 d](/filings/0000720858-25-000032.md) | [3.7 d](/filings/0000720858-26-000011.md) | [0.6](/filings/0000720858-26-000017.md) | [6.3 d](/filings/0000720858-26-000030.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.3](/filings/0000720858-23-000008.md) | [36.2](/filings/0000720858-24-000003.md) | [36.3](/filings/0000720858-26-000011.md) | [35.1](/filings/0000720858-26-000011.md) | [40.9](/filings/0000720858-26-000011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [287.1%](/filings/0000720858-23-000008.md) | [65.9%](/filings/0000720858-24-000003.md) | [59.7%](/filings/0000720858-26-000011.md) | [88.4%](/filings/0000720858-26-000011.md) | [86.0%](/filings/0000720858-26-000011.md) |
| Diluted EPS | $ per share | [35.28](/filings/0000720858-23-000008.md) | [12.59](/filings/0000720858-24-000003.md) | [11.45](/filings/0000720858-26-000011.md) | [16.43](/filings/0000720858-26-000011.md) | [18.57](/filings/0000720858-26-000011.md) |
| Free cash flow | $m | [45.4](/filings/0000720858-23-000008.md) | [30.5](/filings/0000720858-24-000003.md) | [(1.8)](/filings/0000720858-26-000011.md) | [22.4](/filings/0000720858-26-000011.md) | [25.4](/filings/0000720858-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/itic/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Markel Group Inc.](/funds/1096343.md) | 2026-06-30 | $58.4m | 213,300 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $32.1m | 117,152 |  | Added +7,319 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $20.2m | 73,844 |  | Added +779 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $16.6m | 60,664 |  | Added +47 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $14.9m | 54,453 |  | Added +3,805 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.8m | 39,626 |  | Added +2,358 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.3m | 30,343 |  | Added +727 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $7.9m | 28,797 |  | Reduced −2,301 |
| [THIRD AVENUE MANAGEMENT LLC](/funds/1099281.md) | 2026-06-30 | $6.0m | 21,894 |  | Unchanged |
| [Aristides Capital LLC](/funds/1595521.md) | 2026-06-30 | $5.6m | 20,483 |  | Added +1,530 |

## Recent filings

[All 494 filings](/companies/itic/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 17:26 ET | [10-Q](/filings/0000720858-26-000030.md) | Quarterly report, period 2026-06-30 | 0000720858-26-000030 |
| 2026-08-06 | 08:31 ET | [8-K](/filings/0000720858-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000720858-26-000027 |
| 2026-05-20 | 16:59 ET | [8-K](/filings/0000720858-26-000020.md) | 5.07 Shareholder vote results | 0000720858-26-000020 |
| 2026-05-11 | 17:14 ET | [10-Q](/filings/0000720858-26-000017.md) | Quarterly report, period 2026-03-31 | 0000720858-26-000017 |
| 2026-05-07 | 08:33 ET | [8-K](/filings/0000720858-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000720858-26-000014 |
| 2026-04-13 | 10:00 ET | [DEF 14A](/filings/0001140361-26-014376.md) | Proxy statement, period 2026-05-20 | 0001140361-26-014376 |
| 2026-03-16 | 17:21 ET | [10-K](/filings/0000720858-26-000011.md) | Annual report, period 2025-12-31 | 0000720858-26-000011 |
| 2026-02-17 | 08:33 ET | [8-K](/filings/0000720858-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000720858-26-000006 |
| 2025-11-07 | 16:55 ET | [10-Q](/filings/0000720858-25-000032.md) | Quarterly report, period 2025-09-30 | 0000720858-25-000032 |
| 2025-11-05 | 08:30 ET | [8-K](/filings/0000720858-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000720858-25-000030 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000720858-26-000011.md), filed Mar 16, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/696b0321-ced8-41c5-aec2-05b7c68bf180)

## About the filer

- CIK: 720858
- Tickers: ITIC
- Exchange: Nasdaq
- SIC code: 6361 Title Insurance
- State of incorporation: NC
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.